ELI LILLY & Co (LLY) vs PFIZER INC(PFE)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | LLY | PFE |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $65.18B | $62.58B |
| Revenue growth (YoY) | ▲ 44.7% | ▼ 1.6% |
| Net income | $20.64B | $7.81B |
| Gross margin | — | — |
| Diluted EPS | $22.95 | $1.36 |
| Insider net (6 mo) | −31.0K sh · 5 sells · 0 buys | +130.5K sh · 2 sells · 3 buys |
| Institutional owners | 51 | 44 |
| Institutional value held | $533.23B | $61.93B |
| Next earnings (est.) | Around Oct 29, 2026 | Nov 3, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About ELI LILLY & Co (LLY)
Eli Lilly and Company, incorporated in Indiana in 1901 and tracing its roots to a drug manufacturing business founded in 1876, operates as a single-segment human pharmaceutical company focused on discovering, developing, manufacturing, and marketing innovative
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across b
Source: SEC EDGAR.